The Egyptian stock market witnessed a downturn in healthcare and pharmaceutical stocks during today's trading session. Nile Pharma and Chemical Industries' stock took the biggest hit, plummeting 7.36% to close at 273.30 Egyptian pounds. This significant decline led the sector's losses, reflecting a challenging day for investors in the healthcare industry.
Following Nile Pharma, Alexandria Medical Services' stock suffered a 6.95% decline, closing at 39.36 Egyptian pounds. Alexandria Pharmaceuticals and Chemical Industries also saw a notable drop of 4.55%, ending the session at 1373.94 Egyptian pounds. Additionally, Nazeha International Hospital's stock fell 4.59% to 16.63 Egyptian pounds, while Spied Medical's stock decreased by 3.87% to 0.348 Egyptian pounds.
Other healthcare stocks that experienced declines included Macro Group for Medical Preparations, which fell 3.50% to close at 1.38 Egyptian pounds. Memphis Pharmaceuticals and Chemical Industries' stock dropped 3.41% to 312 Egyptian pounds, and Cleopatra Hospital's stock decreased by 2.96% to 14.10 Egyptian pounds. Furthermore, Seba International Pharmaceuticals' stock declined 2.81% to 5.19 Egyptian pounds.
The downward trend continued with October Pharma's stock falling 2.58% to close at 201.57 Egyptian pounds. Medical Containers' stock dropped 2.50% to 1.56 Egyptian pounds, and Ibn Sina Pharma's stock decreased by 2.31% to 11 Egyptian pounds. Moreover, Mina Pharm for Pharmaceuticals and Chemical Industries' stock declined 2.27% to 770.74 Egyptian pounds.
Some pharmaceutical stocks managed to buck the trend, however. Egyptian Pharmaceutical Industries' stock rose 2.81% to close at 268.99 Egyptian pounds. Rameda, the 10th of Ramadan for Pharmaceutical Industries and Diagnostic Preparations, saw a 2.55% increase to 5.22 Egyptian pounds. Additionally, Future Care for Medical Industries' stock grew 1.04% to 7.79 Egyptian pounds.
Cairo Pharmaceuticals and Chemical Industries' stock experienced a modest increase of 0.25%, closing at 594.11 Egyptian pounds. On the other hand, GlaxoSmithKline's stock declined 1.69% to 297.98 Egyptian pounds, and Premium HealthCare Group's stock fell 1.22% to 0.081 Egyptian pounds.
In terms of trading values, Nile Pharma led the sector with 119.6 million Egyptian pounds in transactions. Memphis Pharmaceuticals followed with 95 million Egyptian pounds, while Alexandria Medical Services and Ibn Sina Pharma recorded 71 million and 67.9 million Egyptian pounds, respectively. Seba International Pharmaceuticals also saw significant trading activity, with 61.3 million Egyptian pounds.
Key points
- Nile Pharma and Chemical Industries' stock plummeted 7.36%
- Several healthcare stocks declined, while a few saw gains
- Trading values were led by Nile Pharma with 119.6 million Egyptian pounds
